Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The eukaryotic translation initiation factor 3, subunit F pseudogene (ENSG00000255996, LOC390282) is a genomic DNA sequence similar to the protein-coding gene EIF3F, but it has acquired mutations and alterations that prevent it from producing a functional protein[5][3]. Such pseudogenes may occasionally be transcribed and could, in some instances, have regulatory functions through their RNA transcripts, such as acting as microRNA sponges or producing regulatory RNAs[2][4][1]. However, there is no evidence indicating ENSG00000255996 itself has any direct biological function, involvement in disease, or therapeutic relevance. It is primarily annotated as a non-functional pseudogene in genomic databases[3][5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on eukaryotic translation initiation factor 3, subunit F pseudogene (null).